Natural Products and Bioprospecting    2012, Vol. 2 Issue (2) : 87-91     DOI: 10.1007/s13659-012-0017-0
Regular Article |
Glucosamine increases the expression of YKL-40 and osteogenic marker genes in hMSC during osteogenic differentiation
Ramona LIEDERa,b, Sigrídur Thóra REYNISDÓTTIRa, Finnbogi THORMÓDSSONe, Chuen-How NGc, Jon Magnús EINARSSONc, Jóhannes GÍSLASONc, Jóhannes BJÖRNSSONd,f, Sveinn GUDMUNDSSONa, Pétur Henry PETERSENe, Ólafur Eysteinn SIGURJÓNSSONa,b,d
a The Blood Bank, Landspitali University Hospital, Snorrabraut 60, 105 Reykjavik, Iceland;
b School of Science and Engineering, Reykjavik University, Menntavegi 1, 101 Reykjavik, Iceland;
c Genis ehf, Vatnagördum 18, 104 Reykjavik, Iceland;
d Biomedical Center, University of Iceland, Vatnsmyrarvegi 16, 101 Reykjavik, Iceland;
e Department of Anatomy, Medical Faculty, University of Iceland, Vatnsmyrarvegi 16, 101 Reykjavik, Iceland;
f Department of Pathology, Landspitali University Hospital, Baronsstig, 101 Reykjavik, Iceland
Download: PDF(1422 KB)   HTML ()  
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Abstract  Human mesenchymal stem cells(hMSC) can be expanded in vitro and differentiated towards osteogenic, chondrogenic or adipogenic lineages, making them an attractive source for tissue engineering and regenerative medicine. Chitinase-like-proteins(CLPs) belong to the family 18 glycosyl hydrolases and are believed to play a role in inflammation and tissue remodelling. The aim of this study was to determine the effect of the aminosugar glucosamine on the expression of the CLP YKL-40 during osteogenic differentiation of hMSC. Glucosamine did not affect multipotency of hMSC nor proliferation rate of undifferentiated hMSC. YKL-40 was expressed during both expansion of undifferentiated hMSC and during osteogenic differentiation. A slight but nonsignificant increase in YKL-40 expression was observed with glucosamine, accompanied by a pH-dependent delay in mineralization. However, glucosamine induced higher expression of osteogenic marker genes.
Keywords YKL-40      mesenchymal stem cells      osteogenic differentiation      chitinase-like-protein     
Fund:This work was supported by grants from Technology Development Fund, managed by the Icelandic Center for Research, and Landspitali University Hospital Research Fund.
Issue Date: 11 February 2018
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Ramona LIEDER
Sigrídur Thóra REYNISDÓTTIR
Finnbogi THORMÓDSSON
Chuen-How NG
Jon Magnús EINARSSON
Jóhannes GÍSLASON
Jóhannes BJÖRNSSON
Sveinn GUDMUNDSSON
Pétur Henry PETERSEN
Ólafur Eysteinn SIGURJÓNSSON
Trendmd:   
Cite this article:   
Ramona LIEDER,Sigrídur Thóra REYNISDÓTTIR,Finnbogi THORMÓDSSON, et al. Glucosamine increases the expression of YKL-40 and osteogenic marker genes in hMSC during osteogenic differentiation[J]. Natural Products and Bioprospecting, 2012, 2(2): 87-91.
URL:  
http://npb.kib.ac.cn/EN/10.1007/s13659-012-0017-0     OR     http://npb.kib.ac.cn/EN/Y2012/V2/I2/87
[1] Sakaguchi, Y.; Sekiya, I.; Yagishita, K.; Muneta, T. Arthritis Rheum. 2005, 52, 2521-2529.
[2] Zuk, P. A.; Zhu, M.; Mizuno, H.; Huang, J.; Futrell, J. W.; Katz, A. J.; Benhaim, P.; Lorenz, H. P.; Hedrick, M. H. Tissue Eng. 2001, 7, 211-228.
[3] Jiang, Y.; Jahagirdar, B. N.; Reinhardt, R. L.; Schwartz, R. E.; Keene, C. D.; Ortiz-Gonzalez, X. R.; Reyes, M.; Lenvik, T.; Lund, T.:Blackstad, M.; Du, J.; Aldrich, S.; Lisberg, A.; Low, W. C.; Largaespada, D. A.; Verfaillie, C. M. Nature 2002, 418, 41-49.
[4] Bleau, G.; Massicotte, F.; Merlen, Y.; Boisvert, C. EXS 1999, 87, 211-221.
[5] Lee, C. G. Yonsei Med. J. 2009, 50, 22-30.
[6] Recklies, A. D.; Ling. H.; White, C.; Bernier, S. M. J. Biol. Chem. 2005, 280, 41213-41221.
[7] Bussink, A. P.; Speijer, D.; Aerts, J. M.; Boot, R. G. Genetics 2007, 177, 959-970.
[8] Renkema, G. H.; Boot, R. G.; Au, F. L.; Donker-Koopman, W. E.; Strijland, A.; Muijsers, A. O.; Hrebicek, M.; Aerts, J. M. Eur. J. Biochem. 1998, 251, 504-509.
[9] Holt, P. G. Toxicol. Lett. 1996, 86, 205-210.
[10] Houston, D. R.; Recklies, A. D.; Krupa, J. C.; van Aalten, D. M. J. Biol. Chem. 2003, 278, 30206-30212.
[11] Hakala, B. E.; White, C.; Recklies, A. D. J. Biol. Chem. 1993, 268, 25803-25810.
[12] Ling, H.; Recklies, A. D. Biochem. J. 2004, 380, 651-659.
[13] Sandford, P. A. Advances in Chitin Science; NTNU:Trondheim, 2003; pp. 35-42.
[14] Kirkham, S. G.; Samarasinghe, R. K. J. Orthop. Surg. (Hong Kong) 2009, 17, 72-76.
[15] Meininger, C. J.; Kelly, K. A.; Li, H.; Haynes, T. E.; Wu, G. Biochem. Biophys. Res. Commun. 2000, 279, 234-239.
[16] Ivanovska, N.; Dimitrova, P. Arthritis Res. Ther. 2011, 13, R44.
[17] Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Cytotherapy 2006, 8, 315-317.
[18] Bergkvist, A.; Rusnakova, V.; Sindelka, R.; Garda, J. M.; Sjogreen, B.; Lindh, D.; Forootan, A.; Kubista, M. Methods 2010, 50, 323-335.
[19] Disthabanchong, S.; Radinahamed, P.; Stitchantrakul, W.; Hongeng, S.; Rajatanavin, R. Kidney Int. 2007, 71, 201-209.
[20] Ganno, T.; Yamada, S.; Ohara, N.; Matsunaga, T.; Yanagiguchi, K.; Ikeda, T.; Ishizaki, H.; Hayashi, Y. J. Biomed. Mater. Res. A 2007, 82, 188-194.
No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed